Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare carcinoma with a poor prognosis, characterized by the presence of a mixture of exocrine and neuroendocrine malignant epithelial cells in both the pancreas and metastatic sites. Symptoms include jaundice, abdominal pain, and weight loss.
Biomarker and diagnostic research for pancreatic carcinoma with mixed differentiation has been reported in the published literature.
No clinical trials have been registered for pancreatic carcinoma with mixed differentiation.
45 publications have been identified in PubMed for pancreatic carcinoma with mixed differentiation. Research spans Case Report / Case Series (40%), Review / Meta-Analysis (20%), and Diagnostic / Biomarker (16%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 18 | 40% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 11:13 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries
9 |
20% |
Testing and diagnosis research | 7 | 16% |
Laboratory research | 4 | 9% |
Disease patterns and progression | 4 | 9% |
Clinical study results | 3 | 7% |
Butt BP (2026). [PMID: 41911950](https://pubmed.ncbi.nlm.nih.gov/41911950/). *J Neuroendocrinol*. [Clinical Trial Publication]
İşler AO (2026). [PMID: 41571237](https://pubmed.ncbi.nlm.nih.gov/41571237/). *Int J Surg Pathol*. [Review / Meta-Analysis]
Arends MJ (2026). [PMID: 41724188](https://pubmed.ncbi.nlm.nih.gov/41724188/). *Histopathology*. [Review / Meta-Analysis]
Kinowaki Y (2026). [PMID: 41830603](https://pubmed.ncbi.nlm.nih.gov/41830603/). *Am J Clin Pathol*. [Diagnostic / Biomarker]
Ergenç M (2026). [PMID: 41998800](https://pubmed.ncbi.nlm.nih.gov/41998800/). *Cancer Control*. [Diagnostic / Biomarker]
Ramamurthy PS (2026). [PMID: 41822604](https://pubmed.ncbi.nlm.nih.gov/41822604/). *Cureus*. [Case Report / Case Series]
Yilmaz O (2026). [PMID: 41905349](https://pubmed.ncbi.nlm.nih.gov/41905349/). *Histopathology*. [Case Report / Case Series]
Klimstra DS (2026). [PMID: 41839438](https://pubmed.ncbi.nlm.nih.gov/41839438/). *Archives of pathology & laboratory medicine*. [Review / Meta-Analysis]
Marinoni I (2026). [PMID: 41238828](https://pubmed.ncbi.nlm.nih.gov/41238828/). *Virchows Archiv : an international journal of pathology*. [Review / Meta-Analysis]
Tashiro Y (2026). [PMID: 40522384](https://pubmed.ncbi.nlm.nih.gov/40522384/). *Abdom Radiol (NY)*. [Review / Meta-Analysis]